Immunotech Biopharm Statistics

Total Valuation

HKG:6978 has a market cap or net worth of HKD 1.46 billion. The enterprise value is 1.90 billion.

Market Cap	1.46B
Enterprise Value	1.90B

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:6978 has 617.50 million shares outstanding.

Current Share Class	617.50M
Shares Outstanding	617.50M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	34.64%
Owned by Institutions (%)	0.04%
Float	222.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-9.14
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.77
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.09

Financial Position

The company has a current ratio of 0.08

Current Ratio	0.08
Quick Ratio	0.04
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-3.99
Interest Coverage	-24.81

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-17.94%
Return on Invested Capital (ROIC)	-28.08%
Return on Capital Employed (ROCE)	2,270.98%
Weighted Average Cost of Capital (WACC)	5.88%
Revenue Per Employee	n/a
Profits Per Employee	-1.42M
Employee Count	173
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, HKG:6978 has paid 1.02 million in taxes.

Income Tax	1.02M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.57% in the last 52 weeks. The beta is 0.57, so HKG:6978's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	-44.57%
50-Day Moving Average	2.64
200-Day Moving Average	3.49
Relative Strength Index (RSI)	43.57
Average Volume (20 Days)	255,728

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-190.12M
Pretax Income	-244.24M
Net Income	-244.91M
EBITDA	-126.75M
EBIT	-190.12M
Earnings Per Share (EPS)	-0.48

Full Income Statement

Balance Sheet

The company has 23.07 million in cash and 471.54 million in debt, giving a net cash position of -448.47 million or -0.73 per share.

Cash & Cash Equivalents	23.07M
Total Debt	471.54M
Net Cash	-448.47M
Net Cash Per Share	-0.73
Equity (Book Value)	-159.42M
Book Value Per Share	-0.30
Working Capital	-499.43M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -100.15 million and capital expenditures -18.11 million, giving a free cash flow of -118.26 million.

Operating Cash Flow	-100.15M
Capital Expenditures	-18.11M
Free Cash Flow	-118.26M
FCF Per Share	-0.19

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HKG:6978 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-16.81%
FCF Yield	-8.12%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1